1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Ostomy Drainage Bags Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Ostomy Drainage Bags Market, North America 9
3.1 Ostomy Drainage Bags Market, North America, Revenue ($m), 2015-2025 9
3.2 Ostomy Drainage Bags Market, North America, Revenue ($m), 2015-2025 11
3.3 Ostomy Drainage Bags Market, North America, Volume (Units), 2015-2025 13
3.4 Ostomy Drainage Bags Market, North America, Volume (Units), 2015-2025 15
3.5 Ostomy Drainage Bags Market, North America, Company Share by Revenue ($m), 2019 17
4 Ostomy Drainage Bags Market, Canada 19
4.1 Ostomy Drainage Bags Market, Canada, Revenue ($m), 2015-2025 19
4.1.1 Colostomy Market, Canada, Revenue ($m), by Segment, 2015-2025 21
4.1.2 Ileostomy Market, Canada, Revenue ($m), by Segment, 2015-2025 23
4.1.3 Urostomy Market, Canada, Revenue ($m), by Segment, 2015-2025 25
4.2 Ostomy Drainage Bags Market, Canada, Volume (Units), 2015-2025 27
4.2.1 Colostomy Market, Canada, Volume (Units), by Segment, 2015-2025 29
4.2.2 Ileostomy Market, Canada, Volume (Units), by Segment, 2015-2025 31
4.2.3 Urostomy Market, Canada, Volume (Units), by Segment, 2015-2025 33
4.3 Ostomy Drainage Bags Market, Canada, Average Price ($), 2015-2025 35
4.4 Ostomy Drainage Bags Market, Canada, Distribution Share by Revenue ($m), 2019 37
4.5 Ostomy Drainage Bags Market, Canada, Company Share by Revenue ($m), 2019 38
5 Ostomy Drainage Bags Market, Mexico 40
5.1 Ostomy Drainage Bags Market, Mexico, Revenue ($m), 2015-2025 40
5.1.1 Colostomy Market, Mexico, Revenue ($m), by Segment, 2015-2025 42
5.1.2 Ileostomy Market, Mexico, Revenue ($m), by Segment, 2015-2025 44
5.1.3 Urostomy Market, Mexico, Revenue ($m), by Segment, 2015-2025 46
5.2 Ostomy Drainage Bags Market, Mexico, Volume (Units), 2015-2025 48
5.2.1 Colostomy Market, Mexico, Volume (Units), by Segment, 2015-2025 50
5.2.2 Ileostomy Market, Mexico, Volume (Units), by Segment, 2015-2025 52
5.2.3 Urostomy Market, Mexico, Volume (Units), by Segment, 2015-2025 54
5.3 Ostomy Drainage Bags Market, Mexico, Average Price ($), 2015-2025 56
5.4 Ostomy Drainage Bags Market, Mexico, Distribution Share by Revenue ($m), 2019 58
5.5 Ostomy Drainage Bags Market, Mexico, Company Share by Revenue ($m), 2019 59
6 Ostomy Drainage Bags Market, United States 61
6.1 Ostomy Drainage Bags Market, United States, Revenue ($m), 2015-2025 61
6.1.1 Colostomy Market, United States, Revenue ($m), by Segment, 2015-2025 63
6.1.2 Ileostomy Market, United States, Revenue ($m), by Segment, 2015-2025 65
6.1.3 Urostomy Market, United States, Revenue ($m), by Segment, 2015-2025 67
6.2 Ostomy Drainage Bags Market, United States, Volume (Units), 2015-2025 69
6.2.1 Colostomy Market, United States, Volume (Units), by Segment, 2015-2025 71
6.2.2 Ileostomy Market, United States, Volume (Units), by Segment, 2015-2025 73
6.2.3 Urostomy Market, United States, Volume (Units), by Segment, 2015-2025 75
6.3 Ostomy Drainage Bags Market, United States, Average Price ($), 2015-2025 77
6.4 Ostomy Drainage Bags Market, United States, Distribution Share by Revenue ($m), 2019 79
6.5 Ostomy Drainage Bags Market, United States, Company Share by Revenue ($m), 2019 80
7 Overview of Key Companies in North America Ostomy Drainage Bags Market 81
7.1 Hollister Inc 81
7.1.1 Company Overview 81
7.2 Coloplast A/S 81
7.2.1 Company Overview 81
7.3 ConvaTec Group Plc 81
7.3.1 Company Overview 81
7.4 B. Braun Melsungen AG 82
7.4.1 Company Overview 82
8 Ostomy Drainage Bags Market Pipeline Products 83
9 Recent Developments 84
9.1 Corporate Communications 84
9.1.1 Feb 10, 2020: Chi-Med highlights updated phase II Savolitinib / Imfinzi combination data in advanced papillary renal cell carcinoma at 2020 ASCO Genitourinary Cancers Symposium 84
9.1.2 Jan 08, 2020: Midatech Pharma: Positive results from MTD201-102 study support subcutaneous route for long-acting octreotide product 85
9.1.3 Jan 08, 2020: Anavex Life Sciences issued new U.S. patent for ANAVEX2-73 treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis 87
9.1.4 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 88
9.1.5 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 88
9.1.6 Sep 13, 2019: FDA clears GE’s AI algorithms to identify pneumothorax 89
9.1.7 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 90
9.1.8 Jul 01, 2019: Medline mourns passing of co-founder Jim Mills 91
9.2 Financial Announcements 92
9.2.1 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 92
9.2.2 Dec 19, 2019: REDBUD LABS STR microfluidic chip enables 1000x faster sample prep for on-cartridge magnetic bead assay 93
9.2.3 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 94
9.2.4 Aug 14, 2019: Coloplast delivers 8% organic growth and solid performance across all business areas 97
9.2.5 Aug 14, 2019: Coloplast announcement no. 07/2019 – 9M interim financial report, 2018/19 97
9.2.6 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 98
9.2.7 Jun 19, 2019: Japan’s MHLW approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for treatment of Relapsed/Refractory FLT3-ITD AML. Expands use to include specimens collected in EDTA 101
9.3 Government and Public Interest 102
9.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 102
9.4 Other Significant Developments 102
9.4.1 Jan 30, 2020: Hollister awarded National, ASCEND Agreements in Ostomy Products with Premier 102
9.5 Strategy And Business Planning 103
9.5.1 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 103
9.5.2 Oct 02, 2019: Hollister announces grand opening of new manufacturing facility in Kaunas, Lithuania 103
10 Appendix 105
10.1 Research Methodology 106
10.1.1 Coverage 106
10.1.2 Secondary Research 106
10.1.3 Primary Research 107
10.1.4 Market Modeling and Forecasting 108
10.1.5 Company Share Analysis 110
10.1.6 Distribution Share Analysis 110
10.1.7 Benchmarking 110
10.2 GlobalData Consulting 111
10.3 Contact Us 111
10.4 Disclaimer 112